awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39239278-22F54FB6-0CA5-43E2-BC71-11DEBE0A155F
Q39239278-22F54FB6-0CA5-43E2-BC71-11DEBE0A155F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39239278-22F54FB6-0CA5-43E2-BC71-11DEBE0A155F
Modeling Natural Killer Cell Targeted Immunotherapies.
P2860
Q39239278-22F54FB6-0CA5-43E2-BC71-11DEBE0A155F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39239278-22F54FB6-0CA5-43E2-BC71-11DEBE0A155F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8cefbdb957eb2077c58f9219369c4f0ba82605a0
P2860
CALGB 150905 (Alliance): rituximab broadens the antilymphoma response by activating unlicensed NK cells.